200
Participants
Start Date
July 15, 2020
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2028
vaccination
Patients will have surgery (followed by vaccination) for managing HPV-related lesions
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER